JOHNSON & JOHNSON
For the period ended Dec 29, 2024. Filed Feb 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 13, 2025
JNJ$285.75+0.8%Stored close · as of Nov 13, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated statements of earnings
Checking your notes…
Johnson & Johnson and subsidiaries consolidated statements of earnings
(Dollars and Shares in Millions Except Per Share Amounts) (Note 1)
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Sales to customers | $88,821 | 85,159 | 79,990 |
| Cost of products sold | 27,471 | 26,553 | 24,596 |
| Gross profit | 61,350 | 58,606 | 55,394 |
| Selling, marketing and administrative expenses | 22,869 | 21,512 | 20,246 |
| Research and development expense | 17,232 | 15,085 | 14,135 |
| In-process research and development impairments | 211 | 313 | 783 |
| Interest income | (1,332) | (1,261) | (490) |
| Interest expense, net of portion capitalized (Note 4) | 755 | 772 | 276 |
| Other (income) expense, net | 4,694 | 6,634 | 810 |
| Restructuring (Note 20) | 234 | 489 | 275 |
| Earnings before provision for taxes on income | 16,687 | 15,062 | 19,359 |
| Provision for taxes on income (Note 8) | 2,621 | 1,736 | 2,989 |
| Net earnings from continuing operations | 14,066 | 13,326 | 16,370 |
| Net earnings from discontinued operations, net of tax (Note 21) | — | 21,827 | 1,571 |
| Net earnings | $14,066 | 35,153 | 17,941 |
| Net earnings per share (Notes 1 and 15) | |||
| Continuing operations - basic | $5.84 | 5.26 | 6.23 |
| Discontinued operations - basic | — | 8.62 | 0.60 |
| Total net earnings per share - basic | $5.84 | 13.88 | 6.83 |
| Continuing operations - diluted | $5.79 | 5.20 | 6.14 |
| Discontinued operations - diluted | — | 8.52 | 0.59 |
| Total net earnings per share - diluted | $5.79 | 13.72 | 6.73 |
| Average shares outstanding (Notes 1 and 15) | |||
| Basic | 2,407.3 | 2,533.5 | 2,625.2 |
| Diluted | 2,429.4 | 2,560.4 | 2,663.9 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.